EP2344168A4 - Antiinfektiöse formulierung und verwendungsverfahren - Google Patents

Antiinfektiöse formulierung und verwendungsverfahren

Info

Publication number
EP2344168A4
EP2344168A4 EP09820801.0A EP09820801A EP2344168A4 EP 2344168 A4 EP2344168 A4 EP 2344168A4 EP 09820801 A EP09820801 A EP 09820801A EP 2344168 A4 EP2344168 A4 EP 2344168A4
Authority
EP
European Patent Office
Prior art keywords
methods
infective formulation
infective
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP09820801.0A
Other languages
English (en)
French (fr)
Other versions
EP2344168A1 (de
Inventor
Ian George Tucker
Zimei Wu
Wayne Frederick Leech
Alawi Fadil Al
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer New Zealand Ltd
Original Assignee
MASTITIS RESEARCH CENTRE Ltd
MASTITIS RES CT Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42106691&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP2344168(A4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by MASTITIS RESEARCH CENTRE Ltd, MASTITIS RES CT Ltd filed Critical MASTITIS RESEARCH CENTRE Ltd
Priority to EP14196825.5A priority Critical patent/EP2893932A1/de
Publication of EP2344168A1 publication Critical patent/EP2344168A1/de
Publication of EP2344168A4 publication Critical patent/EP2344168A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP09820801.0A 2008-09-17 2009-09-15 Antiinfektiöse formulierung und verwendungsverfahren Withdrawn EP2344168A4 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP14196825.5A EP2893932A1 (de) 2008-09-17 2009-09-15 Antiinfektive Formulierung und Verfahren zur Verwendung

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ571347A NZ571347A (en) 2008-09-17 2008-09-17 Anti-infective formulation and methods of use
PCT/NZ2009/000195 WO2010044679A1 (en) 2008-09-17 2009-09-15 Anti-infective formulation and methods of use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP14196825.5A Division EP2893932A1 (de) 2008-09-17 2009-09-15 Antiinfektive Formulierung und Verfahren zur Verwendung

Publications (2)

Publication Number Publication Date
EP2344168A1 EP2344168A1 (de) 2011-07-20
EP2344168A4 true EP2344168A4 (de) 2014-05-21

Family

ID=42106691

Family Applications (2)

Application Number Title Priority Date Filing Date
EP09820801.0A Withdrawn EP2344168A4 (de) 2008-09-17 2009-09-15 Antiinfektiöse formulierung und verwendungsverfahren
EP14196825.5A Withdrawn EP2893932A1 (de) 2008-09-17 2009-09-15 Antiinfektive Formulierung und Verfahren zur Verwendung

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP14196825.5A Withdrawn EP2893932A1 (de) 2008-09-17 2009-09-15 Antiinfektive Formulierung und Verfahren zur Verwendung

Country Status (7)

Country Link
EP (2) EP2344168A4 (de)
CN (1) CN102159221A (de)
AU (1) AU2009304000C1 (de)
BR (1) BRPI0918662A2 (de)
NZ (1) NZ571347A (de)
WO (1) WO2010044679A1 (de)
ZA (1) ZA201102857B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2666314C (en) 2006-10-10 2020-04-21 Wisconsin Alumni Research Foundation Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses
AU2009320504A1 (en) * 2008-11-28 2011-07-07 Mastitis Research Centre Limited Animal treatment formulation and methods of use
BRPI1016082B1 (pt) 2009-04-08 2020-12-22 Wisconsin Alumni Research Foundation selante intramamário de mamilos
CN101865922A (zh) * 2010-05-17 2010-10-20 北京易斯威特生物医学科技有限公司 牛奶体细胞检测试剂盒及方法
AU2014318702B2 (en) * 2013-09-11 2019-11-21 Aim Targeted Therapies, Inc. Hypertonic antimicrobial therapeutic compositions

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3830920A (en) * 1970-10-30 1974-08-20 Wigglesworth Ltd Bactericidal veterinary compositions
WO1998026759A1 (en) * 1996-12-18 1998-06-25 Bimeda Research & Development Limited Antiinfective free intramammary veterinary composition

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1441747A (en) * 1972-10-18 1976-07-07 Lazonby B Veterinary compositions
EP0076068A3 (de) 1981-09-25 1985-05-15 Beecham Group Plc Intramammäre Tierarzneimittelpräparate und Verfahren zu deren Anwendung
US5409697A (en) * 1987-07-01 1995-04-25 Novapharm Research Pty. Ltd. Biocidal composition
WO1995031180A1 (en) * 1992-12-08 1995-11-23 Bimeda Research And Development Limited A veterinary composition
DE69319134D1 (de) * 1992-12-08 1998-07-16 Bimeda Res Dev Ltd Wässerige antibiotische zusammensetzung zu veterinärem gebrauch
RU2165261C1 (ru) 2000-02-24 2001-04-20 Закрытое Акционерное Общество "Нита-Фарм" Средство для лечения маститов у коров
ATE473732T1 (de) * 2001-09-10 2010-07-15 Bimeda Res And Dev Ltd Biosicherheitssytem
US20040197422A1 (en) 2002-12-20 2004-10-07 Pfizer Inc Veterinary compositions for treating mastitis
US20090041859A1 (en) * 2005-04-08 2009-02-12 Mie University Wound Treatment Drugs for External Use
NZ549249A (en) 2006-08-18 2009-10-30 Univ Massey Methods for reducing the incidence of mastitis by administration of keratin
CA2666314C (en) * 2006-10-10 2020-04-21 Wisconsin Alumni Research Foundation Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses
CA2745278C (en) * 2008-12-04 2018-07-24 Merial Limited Intramammary teat sealant

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3830920A (en) * 1970-10-30 1974-08-20 Wigglesworth Ltd Bactericidal veterinary compositions
WO1998026759A1 (en) * 1996-12-18 1998-06-25 Bimeda Research & Development Limited Antiinfective free intramammary veterinary composition

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
J.A.H. JONES ET AL: "Bipp: A case of toxicity?", ORAL SURGERY, ORAL MEDICINE, ORAL PATHOLOGY, vol. 69, no. 6, 1 June 1990 (1990-06-01), pages 668 - 671, XP055110361, ISSN: 0030-4220, DOI: 10.1016/0030-4220(90)90344-R *
N SURVEYOR: "THE ACTION OF BETA-NAPHTHOL AND BISMUTH SUBNITRATE AS INTESTINAL ANTISEPTICS.", BR MED J, 14 December 1895 (1895-12-14), pages 1483 - 1485, XP055096270, Retrieved from the Internet <URL:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2509321/pdf/brmedj08799-0011.pdf> [retrieved on 20140114] *
See also references of WO2010044679A1 *

Also Published As

Publication number Publication date
EP2893932A1 (de) 2015-07-15
CN102159221A (zh) 2011-08-17
AU2009304000B2 (en) 2015-08-06
AU2009304000C1 (en) 2022-04-28
EP2344168A1 (de) 2011-07-20
WO2010044679A1 (en) 2010-04-22
BRPI0918662A2 (pt) 2015-12-01
AU2009304000A1 (en) 2010-04-22
NZ571347A (en) 2010-04-30
ZA201102857B (en) 2012-09-26

Similar Documents

Publication Publication Date Title
IL275881B (en) Methods for using alpha1–il antibodies
HK1172896A1 (zh) 化合物和使用方法
HK1161094A1 (en) Compounds and methods of use
EG27167A (en) Microemulsifiers and methods of making and using same
GB2470698B (en) Dimensional probe and methods of use
EP2364161A4 (de) Zusammensetzungen mit satiogenen und anwendungsverfahren
HK1149933A1 (en) Diazacarbazoles and methods of use
EP2262450A4 (de) Implantate und anwendungsverfahren
GB2474813B (en) Triterpenoid compounds and methods of use thereof
EP2516555A4 (de) Färbemittel und verfahren zu deren verwendung
GB0808557D0 (en) Sampling devices and methods of use
IL210582A0 (en) Deuterated benzylbenzene derivatives and methods of use
EP2268673A4 (de) Polypeptid-polymerkonjugate und verwendungsverfahren dafür
EP2262754A4 (de) Minocyclinverbindungen und anwendungsverfahren dafür
IL236830A0 (en) Diazahomoredene derivatives and methods of using them
IL209548A0 (en) Diazacarbazoles and methods of use
EP2464227A4 (de) Verbindungen und anwendungsverfahren dafür
EP2242854A4 (de) Sirna-verbindungen und verfahren zur verwendung davon
ZA201102518B (en) Modified release formulation and methods of use
ZA201102207B (en) Cinnamandehyde-allicin compositions and their method of use
ZA201102857B (en) Anti-infective formulation and methods of use
IL207827A0 (en) Apoaequorin-containing compositions and methods of using same
EP2247314A4 (de) Kationische kontrastmittel und verfahren zu ihrer verwendung
HK1166953A1 (en) Compositions and methods of use
GB0820804D0 (en) Perinropril composition and method of use thereof

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20110413

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

AX Request for extension of the european patent

Extension state: AL BA RS

DAX Request for extension of the european patent (deleted)
TPAC Observations filed by third parties

Free format text: ORIGINAL CODE: EPIDOSNTIPA

TPAC Observations filed by third parties

Free format text: ORIGINAL CODE: EPIDOSNTIPA

A4 Supplementary search report drawn up and despatched

Effective date: 20140417

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 31/02 20060101ALI20140411BHEP

Ipc: A61K 31/155 20060101ALI20140411BHEP

Ipc: A61K 9/00 20060101ALI20140411BHEP

Ipc: A61K 33/24 20060101AFI20140411BHEP

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: BAYER NEW ZEALAND LIMITED

TPAC Observations filed by third parties

Free format text: ORIGINAL CODE: EPIDOSNTIPA

TPAA Information related to observations by third parties modified

Free format text: ORIGINAL CODE: EPIDOSCTIPA

17Q First examination report despatched

Effective date: 20161123

TPAC Observations filed by third parties

Free format text: ORIGINAL CODE: EPIDOSNTIPA

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20170607